DoW Vision, Translational Research Award
OpenDefense Health Agency Contracting Activity - DHACA · Opportunity number HT942526VRPTRA
Eligibility
Nonprofits are listed as eligible applicants.
- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Description
Summary: The fiscal year 2026 (FY26) Vision Research Program (VRP) Translational Research Award (TRA) supports translational research that transforms a promising discovery into new drugs, devices or clinical practice guidelines that are ready for definitive testing in clinical trials during or by the end of the period of performance. The TRA may be used to support preclinical studies, clinical research or a pilot clinical trial, but not a full-scale clinical trial. Research must align with at least one of the FY26 VRP Focus Areas.
Distinctive Features:
· If developing new drugs or device(s), the research team must include expertise in the regulatory approval process.
· The TRA includes a Partnering Principal Investigator (PI) Option (PPIO) for two PIs, an Initiating PI and a Partnering PI.
· Scored peer review criteria include Research Idea/Rationale, Research Strategy and Feasibility, Impact, Personnel and Post-Award Transition Plan.
· Programmatic review criteria include adherence to the intent of the TRA, contribution to the VRP portfolio, relative impact and relevance to military health.
· The VRP may share FY26 TRA applications and reviews with the National Eye Institute (NEI) for independent funding consideration.
https://cdmrp.health.mil/pubs/press/2026/vrppreann
Funding
| Total program funding | $1,600,000 |
|---|---|
| Award floor | Not listed |
| Award ceiling | Not listed |
| Category | Science and Technology |
| Assistance listing | 12.420 |
Official sources
Last verified on Grants.gov Nov 4, 2026. Grantvello is not affiliated with Grants.gov or Defense Health Agency Contracting Activity - DHACA. The notice on Grants.gov is the binding text.